Best Healthcare Companies in Seoul, South Korea
The 194 best Healthcare companies in Seoul, South Korea in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Kering.
Ranked: Best Healthcare companies in Seoul
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 3D ONS Provider of surgical splint fabrication services | — | — | Funding Raised | 10 | — | — | — | — |
| 2 | ADM Korea Provider of clinical development, regulatory and consulting services | — | — | Public | 177 | — | — | — | — |
| 3 | AFS Company in the health data and AI/ML industries, specializing in hair treatment and medical-grade skincare… | — | — | Funding Raised | 11 | — | — | 26 patents AI-driven dermatological imaging and automated hair follicle analysis devices | — |
| 4 | Altos Biologics Company specializing in the development and marketing of biosimilars | — | — | Funding Raised | 14 | Soon Jae Park CEO | — | 3 patents Therapeutic antibodies for angiogenesis inhibition and multiple sclerosis treatment | — |
| 5 | Alvogen Korea R&D company focused on manufacturing of drugs for multiple therapeutic areas | — | — | Public | 605 | — | PrismicSentryNode.js+12 | — | — |
| 6 | AMPall Medical pump maker. | — | — | Unfunded | — | Yang Hee Bong CEO | — | 16 patents Advanced drug infusion pumps and biomaterial sensing devices for medical diagnostics and therapy | — |
| 7 | Apimez R&D company manufacturing drugs for multiple therapeutic areas | — | — | Funding Raised | — | Yoo In-soo CEO | GnuboardMySQLPHP+6 | — | — |
| 8 | Arcreal Developer of digital transformation technologies in the dentistry industry | — | — | Funding Raised | 7 | Steven Jeon CEO | Node.jsThree.jsTailwind CSS+9 | 56 patents 3D intraoral scanning and digital oral cavity modeling for dental diagnostics and treatment planning. | — |
Top 12 Healthcare companies in Seoul
#1
Series C · Seoul, Seoul · founded 2018 · 20 employees$57.6Mraised▾
Provider of home care services for elderly people
- May 2026Series C$27.5M
- Feb 2024Series B$30M
#2
Acquired · Seoul, Seoul · founded 2012 · 73 employees$48.7Mraised▾
Provider of healthcare platforms, medical information services, and customer management software. The company delivers digital marketing solutions and software optimized for beauty hospitals. It also offers an application for cancer patients and their caregivers, providing community and consultation features.
- Nov 2022Post IPO$48.7M
#3
Acquired · Seoul, Seoul · founded 2018 · 56 employees$17.8Mraised▾
Provider of healthcare strategic consulting services
- Feb 2023Series C$15.2M
- Jan 2020Seed$2.6M
- Jan 2019Seed—
#4
Series B · Seoul, Seoul · founded 2018 · 7 employees$26Mraised▾
Developer of bacteria-mediated immunotherapeutic drugs for multiple diseases. It is used for treating cancer (LB-100 (preclinical), LB-200, LB-300) in the in vivo stage, neurodegenerative diseases (LB-400 (preclinical), LB-500) in the in vivo stage, rheumatoid arthritis (LB-600), and NASH (LB-700). The company has also developed leads for the prevention of hair growth (LB-100f), liver disease (LB-200f), osteoarthritis (LB-300f), and obesity (LB-400f).
- Feb 2021Series B$21M
- Jul 2019Seed$5M
#5
Series B · Seoul, Seoul · founded 2014$19.8Mraised▾
Provider of automated electrochemical immunoassay systems. These systems deliver lab-quality results quickly and accurately using a patented technology. The self-contained consumables require no pre-processing, significantly reducing the time to diagnosis. The systems analyze various biomarkers across multiple disease areas, including tumor markers, cardiovascular disease indicators, sepsis markers, infectious disease indicators, thyroid hormones, metabolic markers, and Alzheimer's disease indicators. Connectivity features include cloud server communication and integration with existing laboratory information systems via standard protocols.
- Nov 2018Series B$14.8M
- Aug 2016Series A$5M
- 2015Series A—
#6
Series A · Seoul, Seoul · founded 2021 · 29 employees$5.8Mraised▾
Operator of a veterinary hospital management support platform intended for animal healthcare. The company builds an animal medical data platform through the veterinary hospital alliance for the advancement of companion animal insurance services and the commerce industry, providing people with a cloud-based veterinary hospital electronic chart (EMR) program.
- May 2022Series A$5.8M
#7
Public · Seoul, Seoul · founded 2015 · 18 employees$11.4Mraised▾
Future Medicine is developing therapies for treating inflammation, fibrosis, and cancer. They have developed their own nucleoside library platform for developing and reformulating drug candidates. Their molecules have mainly completed the preclinical phase, which are used for treating nonalcoholic fatty liver disease, glaucoma, COPD, and cancer.
- May 2019Series B$6M
- Jul 2018Series A$5.4M
#8
Series A · Seoul, Seoul · founded 2020$5Mraised▾
Developer of a medical data software designed for dementia prevention. The company's software collects and analyzes patients' lifelog biometric data to provide individualized prevention services and provides cognitive improvement content that is designed for specific areas of the brain, enabling medical professionals to improve the health and safety of patients.
#9
Series B · Seoul, Seoul · founded 2011 · 22 employees$6.6Mraised▾
Developer of digital health platform intended to connect international patients with doctors. The company offers consultation with a doctor and recommends the clinic with service managers accompanying the clients throughout their stay, enabling medical tourists to create a new lifestyle that increases the value of life through treatments.
- Apr 2020Series B$4.9M
- Nov 2018Seed$1.7M
#10
Series A · Seoul, Seoul · founded 2017 · 9 employees$4.9Mraised▾
Provider of exosome-based aesthetic solutions, derma cosmetics, and raw materials. The company researches and develops cosmetic ingredients, including stem cell exosomes. It offers a range of aesthetic products and topical cosmetics. The business focuses on solutions related to skin aging.
- Feb 2021Series A$2.7M
#11
Seed · Seoul, Seoul · founded 2017 · 12 employees$3.3Mraised▾
Operator of a fitness company intended for fitness and curating healthy diet foods. The company's platform combines customer relationship management along with online food optimized for an environment where anyone can easily start exercising and maintain a healthy lifestyle, enabling clients to exercise effectively and supplemented by diet guidance by professional coaches.
- May 2020Seed$2.8M
- 2019Seed$433.3K
#12
Seed · Seoul, Seoul · founded 2017 · 58 employees$1.3Mraised▾
Provider of a group physical training service intended to offer a differentiated fitness service. The company provides an optimized group matching service according to an individual's physique, exercise levels, and goals, enabling users to get customized programs that combine offline classes and online home training.
- Jun 2019Seed$1.3M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.